Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Setareh Dashti Shokoohi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Translational Medicine|February 19, 2026
CAR-T cell immunotherapy in rhabdomyosarcomaPooria Safarzadeh Kozani, Setareh Dashti Shokoohi, Pouya Safarzadeh Kozani
Cancer Cell International|February 24, 2025
Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapiesFatemeh Nasiri, Pouya Safarzadeh Kozani, Faeze Salem, et al.
Frontiers in Immunology|December 26, 2023
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killerFatemeh Nasiri, Khadijeh Farrokhi, Pouya Safarzadeh Kozani, et al.
Frontiers in Immunology|December 9, 2022
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devilFatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Translational Medicine|February 19, 2026
CAR-T cell immunotherapy in rhabdomyosarcomaPooria Safarzadeh Kozani, Setareh Dashti Shokoohi, Pouya Safarzadeh Kozani
Cancer Cell International|February 24, 2025
Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapiesFatemeh Nasiri, Pouya Safarzadeh Kozani, Faeze Salem, et al.
Frontiers in Immunology|December 26, 2023
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killerFatemeh Nasiri, Khadijeh Farrokhi, Pouya Safarzadeh Kozani, et al.
Frontiers in Immunology|December 9, 2022
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devilFatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, et al.
Pageof 1